Redwood Pharma arranging partnering meetings during JPMorgan Healthcare Conference 2020 in San Francisco
Redwood Pharma will be arranging RP101 partnering meetings during the upcoming JPMorgan Healthcare Conference between Jan. 13 and Jan. 15, 2020 in San Francisco, CA.Redwood Pharma is a Sweden-based ophthalmic company seeking partnering, development and other business collaborations for RP101, our lead program. RP101 is a novel, topical treatment for post-menopausal women suffering from chronic, moderate-to-severe dry eye disease (DED). This Phase II product candidate consists of a low-dose estrogen analog formulated in IntelliGel, a proprietary controlled-release drug delivery platform,